Silybin b and cianidanol inhibit Mpro and spike protein of SARS-CoV-2: Evidence from in silico molecular docking studies

  1. Srivastava, R.
  2. Tripathi, S.
  3. Unni, S.
  4. Hussain, A.
  5. Haque, S.
  6. Dasgupta, N.
  7. Singh, V.
  8. Mishra, B.N.
Aldizkaria:
Current Pharmaceutical Design

ISSN: 1873-4286 1381-6128

Argitalpen urtea: 2021

Alea: 27

Zenbakia: 32

Orrialdeak: 3476-3489

Mota: Artikulua

DOI: 10.2174/1381612826666201210122726 GOOGLE SCHOLAR